- Service Name
G4X
- Industry
Biotechnology, Genomics, Sequencing Technology, Spatial Sequencing
- Main Value Proposition
G4X offers rapid and scalable multiomic research capabilities, enabling researchers to gain precision insights at a subcellular level.
- Description
G4X is an ultra high-throughput spatial sequencing platform designed for integrated multiomic analysis of FFPE samples at subcellular resolution. It combines high-throughput in situ multiomics with fast, flexible next-generation sequencing capabilities.
- Key Features
Ultra high-throughput spatial sequencing; Integrated multiomic analysis of RNA, Protein, and H&E; Fast sample-to-discovery in 3 days; High-resolution imaging with a 40cm² area
- Use Cases
Research in genomics and molecular biology; Clinical applications requiring detailed tissue analysis; Pharmaceutical development and biomarker discovery
- Competitive advantages
Combines two powerful sequencing technologies in one platform; Delivers results faster with a 3-day sample-to-discovery timeline; Offers unmatched throughput with the ability to process 20 samples per week
- Strengths
The G4X platform is characterized by its high throughput, flexibility in sequencing options, and the ability to provide detailed insights into multiomic data.
- Positioning
G4X positions itself as a cutting-edge solution for researchers needing high-throughput and high-resolution spatial sequencing capabilities.
- Audience
Target users include genomic researchers, clinical laboratories, and pharmaceutical companies looking for advanced sequencing solutions.
- CTA
Explore G4X
- Tags
Spatial Sequencing
Multiomics
Next-Generation Sequencing
High-Throughput
- Tagline
A New Era of Multiomic Discovery
- Tone of Voice
Innovative, collaborative, purposeful
- Differentiation
G4X uniquely integrates high-throughput spatial sequencing with next-generation sequencing, providing a singular platform that addresses the challenges faced by researchers in genomics.
- Brand Positioning
Singular Genomics is positioned as an innovative leader in genomic technologies, focused on accelerating advancements in science and medicine.
- Founded
2016-01-01
- Founders
Drew Spaventa
Eli Glezer